• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gleason 4级前列腺腺癌模式:泌尿生殖病理学家之间的观察者间一致性研究

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.

作者信息

Kweldam Charlotte F, Nieboer Daan, Algaba Ferran, Amin Mahul B, Berney Dan M, Billis Athanase, Bostwick David G, Bubendorf Lukas, Cheng Liang, Compérat Eva, Delahunt Brett, Egevad Lars, Evans Andrew J, Hansel Donna E, Humphrey Peter A, Kristiansen Glen, van der Kwast Theodorus H, Magi-Galluzzi Cristina, Montironi Rodolfo, Netto George J, Samaratunga Hemamali, Srigley John R, Tan Puay H, Varma Murali, Zhou Ming, van Leenders Geert J L H

机构信息

Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands.

Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands.

出版信息

Histopathology. 2016 Sep;69(3):441-9. doi: 10.1111/his.12976. Epub 2016 May 24.

DOI:10.1111/his.12976
PMID:27028587
Abstract

AIMS

To assess the interobserver reproducibility of individual Gleason grade 4 growth patterns.

METHODS AND RESULTS

Twenty-three genitourinary pathologists participated in the evaluation of 60 selected high-magnification photographs. The selection included 10 cases of Gleason grade 3, 40 of Gleason grade 4 (10 per growth pattern), and 10 of Gleason grade 5. Participants were asked to select a single predominant Gleason grade per case (3, 4, or 5), and to indicate the predominant Gleason grade 4 growth pattern, if present. 'Consensus' was defined as at least 80% agreement, and 'favoured' as 60-80% agreement. Consensus on Gleason grading was reached in 47 of 60 (78%) cases, 35 of which were assigned to grade 4. In the 13 non-consensus cases, ill-formed (6/13, 46%) and fused (7/13, 54%) patterns were involved in the disagreement. Among the 20 cases where at least one pathologist assigned the ill-formed growth pattern, none (0%, 0/20) reached consensus. Consensus for fused, cribriform and glomeruloid glands was reached in 2%, 23% and 38% of cases, respectively. In nine of 35 (26%) consensus Gleason grade 4 cases, participants disagreed on the growth pattern. Six of these were characterized by large epithelial proliferations with delicate intervening fibrovascular cores, which were alternatively given the designation fused or cribriform growth pattern ('complex fused').

CONCLUSIONS

Consensus on Gleason grade 4 growth pattern was predominantly reached on cribriform and glomeruloid patterns, but rarely on ill-formed and fused glands. The complex fused glands seem to constitute a borderline pattern of unknown prognostic significance on which a consensus could not be reached.

摘要

目的

评估个体Gleason 4级生长模式的观察者间可重复性。

方法与结果

23名泌尿生殖病理学家参与了对60张选定高倍照片的评估。所选病例包括10例Gleason 3级、40例Gleason 4级(每种生长模式10例)和10例Gleason 5级。要求参与者为每个病例选择单一主要的Gleason分级(3级、4级或5级),并指出主要的Gleason 4级生长模式(如果存在)。“共识”定义为至少80%的一致性,“倾向”定义为60%-80%的一致性。60例病例中有47例(78%)达成了Gleason分级的共识,其中35例被归为4级。在13例未达成共识的病例中,形态不佳(6/13,46%)和融合(7/13,54%)模式参与了分歧。在至少有一名病理学家将形态不佳的生长模式归为某级的20例病例中,无一例(0%,0/20)达成共识。融合、筛状和肾小球样腺体模式的共识分别在2%、23%和38%的病例中达成。在35例(26%)达成Gleason 4级共识的病例中,有9例参与者对生长模式存在分歧。其中6例的特征是上皮细胞大量增生,其间有纤细的纤维血管核心,这些病例被交替指定为融合或筛状生长模式(“复杂融合”)。

结论

Gleason 4级生长模式的共识主要在筛状和肾小球样模式上达成,但在形态不佳和融合腺体上很少达成。复杂融合腺体似乎构成了一种预后意义不明的临界模式,无法达成共识。

相似文献

1
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.Gleason 4级前列腺腺癌模式:泌尿生殖病理学家之间的观察者间一致性研究
Histopathology. 2016 Sep;69(3):441-9. doi: 10.1111/his.12976. Epub 2016 May 24.
2
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议:分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
3
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.SOCS3免疫组化表达似乎支持2005年和2014年国际泌尿病理学会(ISUP)改良的Gleason分级系统。
Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.
4
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.前列腺癌Gleason分级的观察者间可重复性:泌尿外科病理学家。
Hum Pathol. 2001 Jan;32(1):74-80. doi: 10.1053/hupa.2001.21134.
5
Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.前列腺针芯活检组织中高 Gleason 评分 8 至 10 分腺癌的常见和不常见组织学形态。
Am J Surg Pathol. 2012 Jun;36(6):900-7. doi: 10.1097/PAS.0b013e3182495dee.
6
Interobserver variability in Gleason histological grading of prostate cancer.前列腺癌Gleason组织学分级的观察者间变异性。
Scand J Urol. 2016 Dec;50(6):420-424. doi: 10.1080/21681805.2016.1206619. Epub 2016 Jul 14.
7
Interobserver reproducibility of Gleason grading of prostatic adenocarcinoma among general pathologists.普通病理学家对前列腺腺癌进行Gleason分级的观察者间可重复性。
Indian J Cancer. 2011 Oct-Dec;48(4):488-95. doi: 10.4103/0019-509X.92277.
8
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.当代前列腺癌的Gleason分级:结合对实施2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议实际问题的讨论进行更新
Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820.
9
Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.前列腺癌Gleason分级的观察者间再现性:普通病理学家
Hum Pathol. 2001 Jan;32(1):81-8. doi: 10.1053/hupa.2001.21135.
10
A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.日本与美国前列腺癌Gleason分级观察者间可重复性的比较。
Arch Pathol Lab Med. 2005 Aug;129(8):1004-10. doi: 10.5858/2005-129-1004-ACOIRO.

引用本文的文献

1
Exploring the metastatic potential of isolated tumour cells and clusters-cords patterns of ISUP Grade 5 acinar adenocarcinoma of the prostate: a comprehensive morphological analysis.探索前列腺ISUP 5级腺泡腺癌中分离出的肿瘤细胞的转移潜能及簇状-条索状模式:一项全面的形态学分析。
Virchows Arch. 2025 Sep 4. doi: 10.1007/s00428-025-04253-9.
2
Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol.用于前列腺活检诊断评估的人工智能系统的开发与回顾性验证:研究方案
BMJ Open. 2025 Jul 7;15(7):e097591. doi: 10.1136/bmjopen-2024-097591.
3
A Comparison of Magnetic Resonance Imaging Assessment and Biopsy Outcomes with and Without Central Review in Two Swedish Regional Organized Prostate Cancer Testing Programs.
在瑞典两个地区性有组织的前列腺癌检测项目中,磁共振成像评估与活检结果在有和没有中心审查情况下的比较。
Eur Urol Open Sci. 2025 Jun 5;77:32-38. doi: 10.1016/j.euros.2025.05.008. eCollection 2025 Jul.
4
The impact of biopsy core length on the discrepancy in Gleason scores between biopsy and radical prostatectomy specimen.活检组织条长度对活检标本与根治性前列腺切除术标本之间Gleason评分差异的影响。
BJUI Compass. 2025 Mar 4;6(3):e70009. doi: 10.1002/bco2.70009. eCollection 2025 Mar.
5
Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer: Implications for Early Management.2级前列腺癌患者的确诊活检结果:对早期管理的影响
Eur Urol Open Sci. 2025 Feb 12;72:46-53. doi: 10.1016/j.euros.2025.01.012. eCollection 2025 Feb.
6
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.前列腺癌的组织病理学评估和分级:当前的问题和关键方面。
Asian J Androl. 2024 Nov 1;26(6):575-581. doi: 10.4103/aja202440. Epub 2024 Sep 10.
7
Cribriform versus Intraductal: How to Determine the Difference.筛状型与导管内型:如何确定差异
Cancers (Basel). 2024 May 24;16(11):2002. doi: 10.3390/cancers16112002.
8
The presence of cribriform pattern in prostate biopsy and radical prostatectomy is associated with negative postoperative pathological features.前列腺穿刺活检和根治性前列腺切除术中筛状模式的存在与术后病理特征不良相关。
Cent European J Urol. 2024;77(1):22-29. doi: 10.5173/ceju.2023.215. Epub 2024 Jan 10.
9
Harnessing artificial intelligence for prostate cancer management.利用人工智能进行前列腺癌管理。
Cell Rep Med. 2024 Apr 16;5(4):101506. doi: 10.1016/j.xcrm.2024.101506. Epub 2024 Apr 8.
10
Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.尿路上皮病理学家间 MRI 靶向活检的预期影响对 ProScreen 前列腺癌筛查试验:一项试验前验证研究。
World J Urol. 2024 Apr 6;42(1):217. doi: 10.1007/s00345-024-04898-2.